From the South Coast Radiology, Varsity Lakes, Queensland, Australia.
Clin Nucl Med. 2019 Sep;44(9):e529-e531. doi: 10.1097/RLU.0000000000002712.
PSMA PET/CT is known to show uptake in various benign and malignant processes. The following PSMA PET/CT was performed for prostate carcinoma staging (Gleason 3 + 4 left apex; PSA 5.8). It shows incidental diffuse PSMA marrow uptake, not typical for prostate metastatic disease. No treatment had been commenced at the time of the scan. Serology and bone marrow biopsy showed B-cell acute lymphocytic leukemia. Focal PSMA uptake in the right ischium was correlated with a T1 hypointense lesion on a previous MRI and was convincing for a skeletal metastasis. Alternative diagnoses in diffuse skeletal PSMA uptake need therefore to be considered.
PSMA PET/CT 已知在各种良性和恶性过程中显示摄取。进行以下 PSMA PET/CT 是为了进行前列腺癌分期(左侧尖部 Gleason 3+4;PSA 5.8)。它显示偶然的弥漫性 PSMA 骨髓摄取,不符合前列腺转移疾病的典型表现。在扫描时尚未开始治疗。血清学和骨髓活检显示 B 细胞急性淋巴细胞白血病。右侧坐骨的局灶性 PSMA 摄取与之前 MRI 上的 T1 低信号病变相关,强烈提示骨骼转移。因此,需要考虑弥漫性骨骼 PSMA 摄取的其他诊断。